Camlin Fine Sciences Ltd

CAMLINFINE

Company Profile

  • Business description

    Camlin Fine Sciences Ltd is engaged in the research, development, manufacturing, and marketing of specialty chemicals, ingredients, and additive blends. Its broad product portfolio includes Shelf-Life Solutions, Aroma Ingredients, Performance Chemicals, and Health & Wellness. The Company operates through one reporting business segment, Specialty Chemicals. Its products include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), Tert Butylcatechol (TBC), Guaiacol, Veratrole, Xtendra, Nasure, Ezential, adorr, Vitafor, Dinamic, and Biosus. It serves Food & Beverages, Petfood and Rendering, Animal Nutrition, Petrochemicals, Nutrition & Health, Biofuel, Flavours & Fragrances, and other industries, and generates maximum revenue from the domestic market.

  • Contact

    CST Road, Kalina
    Floor 2 to 5, In GS Point
    Santacruz East
    MumbaiMH400 098
    IND

    T: +91 2267001000

    https://www.camlinfs.com

  • Sector

    Basic Materials

    Stock type

    Cyclical

  • Industry

    Specialty Chemicals

    Fiscal Year End

    31 March 2027

    Employees

    1,557

Stocks News & Analysis

stocks

Impact on ASX REIT from David Jones collapse

Store closures could hit landlords.
stocks

This cheap dividend share might be overlooked

Short term pain, long term potential.
stocks

Why Morningstar thinks Anthropic is worth $1.7 trillion

A look at how we arrive at our base-case valuation for the AI lab, along with bull and bear scenarios.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,286.20122.801.34%
CAC 408,233.3094.301.16%
DAX 4026,267.19446.831.73%
Dow JONES (US)52,389.751,104.022.15%
FTSE 10010,782.87108.931.02%
HKSE24,480.2031.250.13%
NASDAQ25,253.14673.712.74%
Nikkei 22559,944.881,169.381.99%
NZX 50 Index14,101.21127.590.91%
S&P 5007,549.94173.082.35%
S&P/ASX 2009,151.30121.601.35%
SSE Composite Index3,662.812.020.06%

Market Movers